A detailed history of Keebeck Alpha, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Keebeck Alpha, LP holds 1,445 shares of CRL stock, worth $236,676. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,445
Holding current value
$236,676
% of portfolio
0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$178.58 - $220.69 $258,048 - $318,897
1,445 New
1,445 $266,000
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $209,692 - $273,029
1,016 Added 100.49%
2,027 $418,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $205,758 - $276,437
1,011 New
1,011 $273,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.33B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.